DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Nureca Limited — Updates

NSE 50 min ago·11 Aug 2026, 11:59 am

Nureca

Nureca Limited has submitted a disclosure to the stock exchanges, complying with the SEBI (Prohibition of Insider Trading) Regulations. This regulatory filing is a standard procedure that requires companies to inform the market about any share transactions or changes in shareholding by their directors, promoters, or key management personnel.

For investors, this update is largely procedural and does not indicate any major corporate event or strategic shift. It ensures transparency by revealing any insider trading activity, which helps maintain market integrity. It is important to note that this disclosure is a routine compliance requirement and does not, by itself, signal any specific news or performance outlook for the company.

Affected stocks

Neutral1 stock

Nureca

NURECA Neutral

₹334.25

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Nureca (NURECA).
Category: Company.

Why it matters

A routine update for Nureca. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Company SEBI

SEBI Order for Compliance - Completion of Recovery Certificate No.4473 of 2022 Mr. Girishkumar Prabhudas Ruparel (PAN: AIPPR8860G) in the matter of Atlanta Infrastructure and Finance Limited.

SEBI · 11 min ago